Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01LDQ
|
||||
Former ID |
DNC011289
|
||||
Drug Name |
Mycophenolic hydroxamic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531203] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H21NO6
|
||||
Canonical SMILES |
CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)NO)OC
|
||||
InChI |
1S/C17H21NO6/c1-9(5-7-13(19)18-22)4-6-11-15(20)14-12(8-24-17(14)21)10(2)16(11)23-3/h4,20,22H,5-8H2,1-3H3,(H,18,19)/b9-4+
|
||||
InChIKey |
XUEGRBSFQYYISJ-RUDMXATFSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Inosine-5'-monophosphate dehydrogenase 1 | Target Info | Inhibitor | [531203] | |
Inosine-5'-monophosphate dehydrogenase 2 | Target Info | Inhibitor | [531203] | ||
BioCyc Pathway | Purine nucleotides degradation | ||||
Urate biosynthesis/inosine 5'-phosphate degradation | |||||
Guanosine nucleotides de novo biosynthesis | |||||
Superpathway of purine nucleotide salvage | |||||
Purine nucleotides de novo biosynthesis | |||||
Guanosine ribonucleotides de novo biosynthesisPWY-6353:Purine nucleotides degradation | |||||
Guanosine ribonucleotides de novo biosynthesis | |||||
PANTHER Pathway | De novo purine biosynthesis | ||||
PathWhiz Pathway | Purine Metabolism | ||||
WikiPathways | Nucleotide Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.